4.6 Article

Epigenetic mechanisms underlying cognitive impairment and Alzheimer disease hallmarks in 5XFAD mice

期刊

AGING-US
卷 8, 期 4, 页码 664-684

出版社

IMPACT JOURNALS LLC
DOI: 10.18632/aging.100906

关键词

Alzheimer disease; neurodegeneration; behavior; cognition; deacetylase; methyltransferase

资金

  1. Spanish MINECO
  2. European Regional Development Funds [SAF-2012-39852, BFU2013-48822-R, CSD2010-00045]

向作者/读者索取更多资源

5XFAD is an early-onset mouse transgenic model of Alzheimer disease (AD). Up to now there are no studies that focus on the epigenetic changes produced as a result of A beta-42 accumulation and the possible involvement in the different expression of related AD-genes. Under several behavioral and cognition test, we found impairment in memory and psychoemotional changes in female 5XFAD mice in reference to wild type that worsens with age. Cognitive changes correlated with alterations on protein level analysis and gene expression of markers related with tau aberrant phosphorylation, amyloidogenic pathway (APP, BACE1), Oxidative Stress (iNOS, Aldh2) and inflammation (astrogliosis, TNF-alpha and IL-6); no changes were found in non-amyloidogenic pathway indicators such as ADAM10. Epigenetics changes as higher CpG methylation and transcriptional changes in DNA methyltransferases (DNMTs) family were found. Dnmt1 increases in younger 5XFAD and Dnmt3a and b high levels in the oldest transgenic mice. Similar pattern was found with histone methyltransferases such as Jarid1a and G9a. Histone deacetylase 2 (Hdac2) or Sirt6., both related with cognition and memory, presented a similar pattern. Taken together, these hallmarks presented by the 5XFAD model prompted its use in assessing different potential therapeutic interventions based on epigenetic targets after earlier amyloid deposition.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Biochemistry & Molecular Biology

Clinical Parameters and Epigenetic Biomarkers of Plaque Vulnerability in Patients with Carotid Stenosis

Laia Carballo-Perich, Dolors Puigoriol-Illamola, Saima Bashir, Mikel Terceno, Yolanda Silva, Carme Gubern-Merida, Joaquin Serena

Summary: This study focuses on epigenetic biomarkers of carotid atherosclerosis and plaque vulnerability, proposing a better patient selection method and providing significant implications for accurate treatment of cardiovascular diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Chemistry, Medicinal

Discovery and In Vivo Proof of Concept of a Highly Potent DualInhibitor of Soluble Epoxide Hydrolase and Acetylcholinesterase forthe Treatment of Alzheimer's Disease

Sandra Codony, Caterina Pont, Christian Grinan-Ferre, Ania Di Pede-Mattatelli, Carla Calvo-Tusell, Ferran Feixas, Silvia Osuna, Julia Jarne-Ferrer, Marina Naldi, Manuela Bartolini, Maria Isabel Loza, Jose Brea, Belen Perez, Clara Bartra, Coral Sanfeliu, Jordi Juarez-Jimenez, Christophe Morisseau, Bruce D. Hammock, Merce Pallas, Santiago Vazquez, Diego Munoz-Torrero

Summary: The advent of multitarget drug discovery has brought hope for the treatment of multifactorial diseases. A new dual inhibitor has shown positive effects on neuroinflammation and memory impairment and exhibits favorable drug properties.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Cell Biology

Cognitive Decline and BPSD Are Concomitant with Autophagic and Synaptic Deficits Associated with G9a Alterations in Aged SAMP8 Mice

Foteini Vasilopoulou, Aina Bellver-Sanchis, Julia Companys-Alemany, Julia Jarne-Ferrer, Alba Irisarri, Veronica Palomera-Avalos, Celia Gonzalez-Castillo, Daniel Ortuno-Sahagun, Coral Sanfeliu, Merce Pallas, Christian Grinan-Ferre

Summary: This study investigates the molecular mechanisms underlying the behavioural and psychological symptoms of dementia (BPSD) in Alzheimer's Disease (AD) patients. It suggests that epigenetic modulation, particularly through G9a methyltransferase and its histone mark (H3K9me2), plays a key role in shaping learning and memory. The study also reveals the association between increased levels of G9a, autophagic deficits, and alterations in synaptic plasticity, providing further understanding of the cognitive decline and BPSD exhibited by the AD model.
Article Biochemistry & Molecular Biology

Antioxidant Molecular Brain Changes Parallel Adaptive Cardiovascular Response to Forced Running in Mice

Clara Bartra, Lars Andre Jager, Anna Alcarraz, Aline Meza-Ramos, Gemma Sanguesa, Ruben Corpas, Eduard Guasch, Montserrat Batlle, Coral Sanfeliu

Summary: Physically active lifestyle has significant implications for the health and well-being, but excessive training can lead to cardiovascular events and impaired brain plasticity. In this study, young adult male mice were subjected to moderate or high-intensity treadmill running for eight weeks. The high-intensity training resulted in decreased weight gain and cardiac hypertrophy, but without hemodynamic overload. It also reduced heart rate and improved motor skills, without impairing recognition or spatial memory.

ANTIOXIDANTS (2022)

Review Clinical Neurology

General anesthesia versus conscious sedation during endovascular treatment in posterior circulation large vessel occlusion: A systematic review and meta-analysis

Mikel Terceno, Saima Bashir, Juan Cienfuegos, Alan Murillo, Victor Augusto Vera-Monge, Laura Pardo, Montserrat Reina, Carme Gubern-Merida, Dolors Puigoriol-Illamola, Laia Carballo, Anna Costa, Maria Buxo, Joaquin Serena, Yolanda Silva

Summary: The optimal choice of anesthetic approach in endovascular treatment of posterior circulation large vessel occlusion (PC-LVO) strokes is still unclear. This meta-analysis compared conscious sedation (CS) and general anesthesia (GA) and found that CS was associated with better clinical outcomes and lower mortality at 3 months. However, there were no significant differences in final reperfusion rates and procedural duration.

EUROPEAN STROKE JOURNAL (2023)

Article Biochemistry & Molecular Biology

Neuroprotective Epigenetic Changes Induced by Maternal Treatment with an Inhibitor of Soluble Epoxide Hydrolase Prevents Early Alzheimer's Disease Neurodegeneration

Clara Bartra, Alba Irisarri, Ainhoa Villoslada, Ruben Corpas, Samuel Aguirre, Elisa Garcia-Lara, Cristina Sunol, Merce Pallas, Christian Grinan-Ferre, Coral Sanfeliu

Summary: Maternal treatment with TPPU during gestation and lactation can prevent or delay memory loss and AD pathology, possibly by modulating the brain's epigenetic machinery and marks.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Pharmacology & Pharmacy

Exosomes-Based Nanomedicine for Neurodegenerative Diseases: Current Insights and Future Challenges

Amanda Cano, Alvaro Munoz-Morales, Elena Sanchez-Lopez, Miren Ettcheto, Eliana B. Souto, Antonio Camins, Merce Boada, Agustin Ruiz

Summary: Neurodegenerative diseases have unknown etiology in many cases and lack effective treatments. The blood-brain barrier poses a challenge for drug delivery. Exosomes, secreted vesicles, have emerged as promising therapeutic tools due to their natural origin and molecular similarities. They are particularly promising for targeting neurodegenerative diseases due to the difficulty of accessing the brain and the complexity of the diseases.

PHARMACEUTICS (2023)

Article Pharmacology & Pharmacy

Cell penetrating peptides-functionalized Licochalcone-A-loaded PLGA nanoparticles for ocular inflammatory diseases: Evaluation of in vitro anti-proliferative effects, stabilization by freeze-drying and characterization of an in-situ forming gel

Ruth M. Galindo-Camacho, Isabel Haro, Maria J. Gomara, Marta Espina, Joel Fonseca, Carlos Martins-Gomes, Antoni Camins, Amelia M. Silva, Maria L. Garcia, Eliana B. Souto

Summary: The biocompatibility of cell penetrating peptides-functionalized Licochalcone-A-loaded PLGA nanoparticles was evaluated in Caco-2 cell lines, demonstrating non-cytotoxicity, while the anti-inflammatory activity of the nanoparticles was tested in RAW 264.7 cell lines. Freeze-drying with different cryoprotectants was performed to prevent particle aggregation and physical stress. An in-situ forming gel based on poloxamer 407 containing Licochalcone-A-loaded PLGA nanoparticles functionalized with B6 and Tet-1 was developed for ocular administration, providing viscoelasticity, suitable mechanical properties, and mucoadhesive performance.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2023)

Article Biochemistry & Molecular Biology

Integration of ligand and structure-based pharmacophore screening for the identification of novel natural leads against Euchromatic histone lysine methyltransferase 2 (EHMT2/G9a)

Abhisek Jana, Rahul Naga, Sougata Saha, Christian Grinan-Ferre, Deb Ranjan Banerjee

Summary: In this study, a new natural lead against Protein Lysine Methyltransferase 2 (EHMT2/G9a) was identified using a blended ligand and structure-based pharmacophore screening approach. EHMT2/G9a is associated with cancer, Alzheimer's, and aging, and is considered an emerging drug target. Two pharmacophores, based on the common features of known inhibitors and the interaction profile of crystal structures, were developed and validated. These pharmacophores were used in combination to screen over 741,543 compounds. The screening process also included tests for drug-likeness and toxicity, and the potential inhibitors were further analyzed through docking, simulation, and comparative analysis.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)

Article Biophysics

Novel customized age-dependent corneal membranes and interactions with biodegradable nanoparticles loaded with dexibuprofen

Gerard Esteruelas, Alba Ortiz, Josefina Prat, Estefania Vega, Montserrat Munoz-Juncosa, Maria Luisa Garcia Lopez, Miren Ettcheto, Antoni Camins, Elena Sanchez-Lopez, Montserrat Pujol

Summary: Ocular inflammation is commonly treated using nonsteroidal anti-inflammatory drugs. Encapsulating these drugs into PLGA nanoparticles allows for better bioavailability. This study investigates the interaction of Dexibuprofen (DXI) nanoparticles with corneal membranes and finds differences in interactions between elder and adult corneal tissues.

COLLOIDS AND SURFACES B-BIOINTERFACES (2023)

Review Biochemistry & Molecular Biology

Licochalcone A: A Potential Multitarget Drug for Alzheimer's Disease Treatment

Jordi Olloquequi, Miren Ettcheto, Amanda Cano, Ana Fortuna, Joana Bicker, Elena Sanchez-Lopez, Cristian Paz, Jesus Urena, Ester Verdaguer, Carme Auladell, Antoni Camins

Summary: Licochalcone A (Lico-A) is a potential neuroprotective agent with various mechanisms of action, including enhancing cognitive activity, inhibiting neuroinflammation, reducing tau phosphorylation, increasing acetylcholine levels, decreasing amyloid plaques, and exerting antioxidant effects. Further research on the underlying mechanisms and targets of Lico-A may provide new insights for the treatment of cognitive disorders and neurodegenerative diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Chemistry, Medicinal

Repurposing of Raltitrexed as an Effective G9a/EHMT2 Inhibitor and Promising Anti-Alzheimer's Agent

Abhisek Jana, Aina Bellver-Sanchis, Christian Grinan-Ferre, Deb Ranjan Banerjee

Summary: In this study, we report for the first time the inhibition of G9a/EHMT2 and the anti-Alzheimer's activities of the drug raltitrexed. Raltitrexed inhibits G9a directly and reduces the levels of H3K9me2/ H3K9 in an AD transgenic worm model. Furthermore, raltitrexed exhibits a safe toxicity/function range and enhances locomotive function in worms, while reducing amyloid beta aggregates.

ACS MEDICINAL CHEMISTRY LETTERS (2023)

Article Pharmacology & Pharmacy

Preclinical Evaluation of an Imidazole-Linked Heterocycle for Alzheimer's Disease

Andrea Bagan, Sergio Rodriguez-Arevalo, Teresa Taboada-Jara, Christian Grinan-Ferre, Merce Pallas, Iria Brocos-Mosquera, Luis F. Callado, Jose A. Morales-Garcia, Belen Perez, Caridad Diaz, Rosario Fernandez-Godino, Olga Genilloud, Milan Beljkas, Slavica Oljacic, Katarina Nikolic, Carmen Escolano

Summary: This study aims to find molecular entities that modulate imidazoline I-2 receptors (I-2-IRs) as potential therapeutic targets for Alzheimer's disease. The findings demonstrate that the new I-2-IR ligands have beneficial effects in neuroprotection, anti-inflammation, and improvement of cognitive impairment, suggesting their potential as a promising therapeutic strategy for neurodegenerative diseases.

PHARMACEUTICS (2023)

Review Biochemistry & Molecular Biology

Caffeic Acid Phenethyl Ester (CAPE): Biosynthesis, Derivatives and Formulations with Neuroprotective Activities

Rebeca Perez, Viviana Burgos, Victor Marin, Antoni Camins, Jordi Olloquequi, Ivan Gonzalez-Chavarria, Henning Ulrich, Ursula Wyneke, Alejandro Luarte, Leandro Ortiz, Cristian Paz

Summary: Neurodegenerative disorders involve the progressive degeneration and death of neurons, and oxidative stress and neuroinflammation play crucial roles in their progression. Two major pathways, Nrf2 and NF-kappa B, have been identified as potential therapeutic targets due to their involvement in oxidative protection and the promotion of cytokine expression, respectively. Caffeic acid phenethyl ester (CAPE), a compound found in propolis, has shown neuroprotective activity by modulating these pathways. This review summarizes the biosynthesis and chemical synthesis of CAPE derivatives and discusses their neuroprotective activity in both in vitro and in vivo studies conducted from 2010 to 2023.

ANTIOXIDANTS (2023)

Article Multidisciplinary Sciences

Metformin restores cognitive dysfunction and histopathological deficits in an animal model of sporadic Alzheimer's disease

Saghar Rabieipoor, Meysam Zare, Miren Ettcheto, Antoni Camins, Mohammad Javan

Summary: This study evaluated the therapeutic effects of metformin in a mouse model of Alzheimer's disease. The results showed that metformin reduced inflammatory cells and reactive astrocytes as well as the dying neurons in the hippocampus region and the cortex, and improved cognitive performance.

HELIYON (2023)

暂无数据